Page last updated: 2024-10-16

choline and Carcinoma, Ductal, Breast

choline has been researched along with Carcinoma, Ductal, Breast in 17 studies

Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"To determine whether measurements of total choline (tCho) by 1H spectroscopy could predict morphological or pathological complete response (pCR) of neoadjuvant treatment and whether breast cancer subgroups are related to prediction accuracy."7.88Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status. ( Chao, SL; Chintinne, M; Drisis, S; Flamen, P; Ignatiadis, M; Lemort, M; Metens, T, 2018)
"To explore factors determining the detection of total choline (tCho) by in vivo MR spectroscopy (MRS) in locally advanced breast cancer and to evaluate the ability of in vivo tCho to predict treatment response after one cycle of neoadjuvant chemotherapy (NAC)."7.77In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. ( Bathen, TF; Bofin, A; Gribbestad, IS; Heldahl, MG; Lundgren, S; Sitter, B; Vettukattil, R, 2011)
"Choline (Cho) signal identification and quantification in (1)H MRS are used in breast cancer diagnosis."5.16Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant? ( Baltzer, PA; Camara, O; Dietzel, M; Gajda, M; Gussew, A; Kaiser, WA; Reichenbach, JR; Rzanny, R, 2012)
"To determine whether measurements of total choline (tCho) by 1H spectroscopy could predict morphological or pathological complete response (pCR) of neoadjuvant treatment and whether breast cancer subgroups are related to prediction accuracy."3.88Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status. ( Chao, SL; Chintinne, M; Drisis, S; Flamen, P; Ignatiadis, M; Lemort, M; Metens, T, 2018)
"To explore factors determining the detection of total choline (tCho) by in vivo MR spectroscopy (MRS) in locally advanced breast cancer and to evaluate the ability of in vivo tCho to predict treatment response after one cycle of neoadjuvant chemotherapy (NAC)."3.77In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. ( Bathen, TF; Bofin, A; Gribbestad, IS; Heldahl, MG; Lundgren, S; Sitter, B; Vettukattil, R, 2011)
"To assess the relationship between breast cancer subtypes and choline detection by using in vivo proton magnetic resonance (MR) spectroscopy and to assess the feasibility of proton MR spectroscopy in the study of axillary lymph node metastases."3.71Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. ( Tse, GM; Yang, WT; Yeung, DK, 2002)
"ER negative breast cancer had bigger tumors compared to ER positive cancer (3."1.35Estrogen receptor and breast MR imaging features: a correlation study. ( Baek, HM; Chen, JH; Nalcioglu, O; Su, MY, 2008)
"Choline peak in vivo is a specific but not sensitive marker of malignancy."1.33Evaluation of spectral selected press sequence in breast lesion characterization. ( Bao, RX; Liu, PF; Lu, H; Sun, F, 2006)
"Choline was observed in all 19 cancer patients, while it was not detected in all other benign diseases."1.32In vivo 1H-MRS evaluation of malignant and benign breast diseases. ( Chung, DS; Kim, JK; Kim, OD; Lee, HM; Lee, YH; Park, SH; Sung, NK, 2003)
"To determine whether invasive breast cancer can be distinguished from benign lesions with proton magnetic resonance (MR) spectroscopy ex vivo on the basis of altered cellular chemistry."1.30Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. ( Barraclough, BH; Barry, PA; Bilous, M; Doran, ST; Gillett, DJ; Lean, CL; Mackinnon, WB; Malycha, PL; Mountford, CE; Russell, P, 1997)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's8 (47.06)29.6817
2010's6 (35.29)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Sodano, C1
Clauser, P1
Dietzel, M2
Kapetas, P1
Pinker, K1
Helbich, TH1
Gussew, A2
Baltzer, PA2
Drisis, S1
Flamen, P1
Ignatiadis, M1
Metens, T1
Chao, SL1
Chintinne, M1
Lemort, M1
Suppiah, S1
Rahmat, K1
Mohd-Shah, MN1
Azlan, CA1
Tan, LK1
Aziz, YF1
Vijayananthan, A1
Wui, AL1
Yip, CH1
Mimmi, MC1
Finato, N1
Pizzolato, G1
Beltrami, CA1
Fogolari, F1
Corazza, A1
Esposito, G1
Sun, K1
Chai, W1
Fu, C1
Zhan, Y1
Shen, K1
Luo, X1
Yan, F1
Rzanny, R1
Gajda, M1
Camara, O1
Reichenbach, JR1
Kaiser, WA1
Bathen, TF1
Heldahl, MG1
Sitter, B1
Vettukattil, R1
Bofin, A1
Lundgren, S1
Gribbestad, IS1
Yeung, DK2
Yang, WT2
Tse, GM2
Kim, JK1
Park, SH1
Lee, HM1
Lee, YH1
Sung, NK1
Chung, DS1
Kim, OD1
King, AD1
Cheung, HS1
Lu, H1
Liu, PF1
Bao, RX1
Sun, F1
Baek, HM2
Chen, JH2
Nalcioglu, O2
Su, MY2
Mackinnon, WB1
Barry, PA1
Malycha, PL1
Gillett, DJ1
Russell, P1
Lean, CL1
Doran, ST1
Barraclough, BH1
Bilous, M1
Mountford, CE1
Malycha, P1
Mountford, C1
Jagannathan, NR1
Kumar, M1
Seenu, V1
Coshic, O1
Dwivedi, SN1
Julka, PK1
Srivastava, A1
Rath, GK1
Cecil, KM1
Schnall, MD1
Siegelman, ES1
Lenkinski, RE1

Reviews

1 review available for choline and Carcinoma, Ductal, Breast

ArticleYear
In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
    Breast cancer research and treatment, 2007, Volume: 104, Issue:3

    Topics: Breast; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Choline; Disease Progression; False

2007

Trials

2 trials available for choline and Carcinoma, Ductal, Breast

ArticleYear
Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?
    NMR in biomedicine, 2012, Volume: 25, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Contrast Media

2012
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
    British journal of cancer, 2001, Apr-20, Volume: 84, Issue:8

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Choline; Combined

2001

Other Studies

14 other studies available for choline and Carcinoma, Ductal, Breast

ArticleYear
Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
    European radiology, 2020, Volume: 30, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast

2020
Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status.
    Journal of magnetic resonance imaging : JMRI, 2018, Volume: 48, Issue:4

    Topics: Adult; Analysis of Variance; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Follow-Up

2018
Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Clinical radiology, 2013, Volume: 68, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Early

2013
Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.
    Analytical cellular pathology (Amsterdam), 2013, Volume: 36, Issue:3-4

    Topics: Acetonitriles; Biomarkers, Tumor; Biopsy; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carci

2013
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.
    European radiology, 2016, Volume: 26, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobu

2016
In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
    Magma (New York, N.Y.), 2011, Volume: 24, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Humans

2011
Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
    Radiology, 2002, Volume: 225, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast;

2002
In vivo 1H-MRS evaluation of malignant and benign breast diseases.
    Breast (Edinburgh, Scotland), 2003, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Diagnosis, Differenti

2003
Evaluation of spectral selected press sequence in breast lesion characterization.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2006, Volume: 21, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Fibroa

2006
Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Ca

2008
Estrogen receptor and breast MR imaging features: a correlation study.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:4

    Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Humans; Lymphatic

2008
Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
    Radiology, 1997, Volume: 204, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast; Breast Neoplasms; Carcinoma in Situ; Carcino

1997
Magnetic resonance spectroscopy and breast cancer.
    The Australian and New Zealand journal of surgery, 1998, Volume: 68, Issue:12

    Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Choline; Creatine; F

1998
The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Breast cancer research and treatment, 2001, Volume: 68, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma,

2001